3-iodobenzylguanidine has been researched along with mitomycin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nishiyama, M; Sakamoto, N; Toge, T | 1 |
Aalders, M; Beijnen, JH; Essers, M; Kuin, A; Lamfers, M; Smets, LA; van Zuidam, DJ | 1 |
2 other study(ies) available for 3-iodobenzylguanidine and mitomycin
Article | Year |
---|---|
Tumor-specific synergistic therapy of mitomycin C: modulation of bioreductive activation.
Topics: 3-Iodobenzylguanidine; Animals; Antibiotics, Antineoplastic; Biotransformation; Cell Division; Dicumarol; DNA Damage; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Iodobenzenes; Mice; Mice, Nude; Mitomycin; NAD(P)H Dehydrogenase (Quinone); NADPH-Ferrihemoprotein Reductase; Neoplasms, Experimental; Rats; Tumor Cells, Cultured | 1997 |
Potentiation of anti-cancer drug activity at low intratumoral pH induced by the mitochondrial inhibitor m-iodobenzylguanidine (MIBG) and its analogue benzylguanidine (BG).
Topics: 3-Iodobenzylguanidine; 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Amiloride; Animals; Antineoplastic Agents; Cell Division; Cell Survival; Chlorambucil; Chromium Radioisotopes; Doxorubicin; Drug Synergism; Edetic Acid; Glucose; Guanidines; Hydrogen-Ion Concentration; Kidney; Leukemia L1210; Melphalan; Mice; Mitomycin; Tumor Cells, Cultured | 1999 |